CD8A and neoplasm: Finally, pseudo-temporal trajectories calculated using Monocle2 demonstrated progression of CD8+ T cells from TEM to both TRM and Tex subtypes, indicating that effector cells do not solely progress towards exhaustion but maintain substantial anti-tumor effects, aligning with contemporary research insights.